Nutrition and chronic alcohol abuse;Nutrición y alcoholismo crónico

Nutricion Hospitalaria

Volumn 23, Issue SUPPL. 2, 2008, Pages 3-7

  Moreno Otero, R ^a   Cortes J R ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Alcohol dependency; Chronic alcohol abuse; Nutritional supports

Indexed keywords

ANTIOXIDANT; GLUTATHIONE;

ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; CELL ACTIVATION; CELL DAMAGE; FIBROGENESIS; HUMAN; LIPID PEROXIDATION; MALNUTRITION; MEMBRANE FLUIDITY; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; OXIDATIVE STRESS; RETINOL DEFICIENCY; REVIEW; STEATOSIS; STELLATE CELL; VITAMIN SUPPLEMENTATION;

ALCOHOLISM; ANTIOXIDANTS; ETHANOL; HUMANS; LIVER DISEASES, ALCOHOLIC; MALNUTRITION; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; OXIDATIVE STRESS;

EID: 46749117644     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Lieber CS. Alcohol: Its metabolism and interaction with nutrients. Ann Rev Nutr 2000; 20:395-430.
2. Pirola RC, Lieber CS. The energy cost of the metabolim of drugs including ethanol. Pharmacology 1972; 7:185-196.
3. Lieber CS. Perspectives: Do alcohol calories count? Am J Clin Nutr 1991; 54:976-982.
4. th ed Baltimore: Williams & Wilkins, 1998. pp. 1523-1542.
5. Gruchow HW, Sobociaski KA, Barboriak JJ. Alcohol nutrient intake an hypertension un U.S. adults. JAMA: Journal of the American Medical Associtaion 1985; 253:1567-1570.
6. Adibi SA, Baraona E, Lieber CS. Effects of ethanol on amino acids and protein metabolism. New York: Plenum Press. 1992; 127-155.
7. Leo MA, Lieber CS. Alcohol, vitamin A, and beta-carotene: Adverse interations, including hepatotoxicity and carcinogenicity. Am J Clin Nutr 1999; 69:1071-1085.
8. Leo MA, Kim C, Lieber CS. Increased vitamin A in esophagus and other extrahepatic tissues after chronic ethanol consumption in the rat. Alcoholism: Clin Exp Res 1986; 10:487-492.
9. Leo MA, Lowe N, Lieber CS. Interaction of ethanol with β-carotene: Delayed blood clearance and enhanced hepatocitity. Hepatology 1992; 15:883-891.
10. Ahmed S, Leo MA, Lieber CS. Interactions between alcohol and beta-carotene in patients with alcoholic liver diseas. J Clin Nutr 1995; 60:430-436.
11. Leo MA, Lieber CS. Hepatic fibrosis after long-term administration of ethanol and moderate vitamin A supplementation in the rat. Hepatology 1983; 3:1-11.
12. Lieber CS. Medical and Nutritional complications of alcoholism: Mechanisms and Management. New York: Plenum Press, 1992.
13. Bode JL, Cuchwald B, Coebell H: Inhibition of ethanol breakdown due to protein deficiency in man. German Medical Monthly 1971; 1:149-151.
14. Lieber CS, Schimid R. The effect of ethanol on fatty acid metabolism: Stimulation of hepatic fatty acid synthesis in vitro. J Clin Inves 1961; 40:394-399.
15. Casini A, Cunningham M, Rojkind M, Lieber CS. Acetaldehyde increases procollagen type I and fibronectin gene transcription in cultured rat fat-storing cells through a protein synthesis-dependent mechanism. Hepatology 1991; 13:758-765.
16. Lieber CS. Cytochrome P-4502E1: Its physiological and pathological role. Physiol Rev 1997; 77:517-544.
17. Tsutsumi M, Lasker JM, Shimizu M y cols. The intralobular distribution of ethanol inducible P450IIE1 in rat and human liver. Hepatology 1989; 10:437-446.
18. Leo MA, Rosman A, Lieber CS. Differential depletion of acrotenoids and tocopherol in liver diseases. Hepatology 1993; 17:977-986.
19. Chedid A, Mendenhall CL, Gartside P y cols. Prognostic factors in alcoholic liver disease. Am J Gastroenterol 1991; 82:210-216.
20. Mendenhall C, Roselle GA, Gartiside P y cols. Relationship of protein caloire malnutrition to alcoholic liver disease: a reexamination of data from two Veterans Administration Cooperative studies. Alcoholism: Clin Exp Res 1995; 19:635-641.
21. Lieber CS, Decarli LM. Quantitative relationship between the amount of dietary fat and the severity of the alcoholic fatty liver. Am J Clin Nutr 1970; 23:474-478.
22. Nanji AA, Yang EK, Fogt F y cols. Medium-Chain triglycerides and vitamin E reduce the severity of established experimental alcoholic liver disease. J Pharmacol Exp Therapeutics 1996; 277:1694-1700.
23. Shaw S, Rubin KP, Lieber CS. Depressed hepatic glutathione and increased diene conjugate in alcoholic liver disease. Evidence of lipid peroxidation. Digest Dis Sci 1983; 28:585-589.
24. Medina J, Moreno-Otero R. Pathophysiological basis for antioxidant therapy in chronic liver disease. Drugs 2005; 65(17):2445-61.
25. Lieber CS. S-adenosylmethionine (SAMe): its role in the treatment of liver disorders. Am J Clin Nutr 2002; 76:1183S-1187S.
26. Mato JM, Cámara J, Fernández de Paz J y cols. S-adenosylmethometionine in alcoholic liver cirrhosis: a randomized placebo-controlled double-blind multicenter clinical trial. J Hepatol 1999; 30:1081-1089.
27. Aleynick DI, Leo MA, Aleynik MK, Lieber CS. Polyenylphosphatidylcholine prevents carbontetracholire-induced lipid peroxidation while it attenuates lever injury and fibrosis. J Hepatol 1997; 26:554-561.
28. Ma X, Zhao J, Lieber CS. Polyenylphosphatidylcholine attenuates non-alcoholic hepatic fibrosis and accelerates in regression. J Hepatol 1996; 24:604-613.
29. Lieber CS, Leo MA, Aleynik SI y cols. Polyenylphosphatidylcholine decrease alcohol induced oxidative stress in the baboon. Alcoholism: Clin Exp Res 1997; 21:375-379.
30. Pares A, Planas R, Torres M y cols. Effects of silymarin in alcoholic patients with cirrhosis of the liver. Resutls of a controlled double-blind randomized and multicenter trial. J Hepatol 1998; 28:615-621.
31. Ferenci P, Dtragosics B, Dittrich H y cols. Randomized controlled trial of silymarin treatment in patients with cirrhosis or the liver. J Hepatol 1989; 9:105-113.